Notes to SEFA
Title: Loan/loan guarantee outstanding balances
Accounting Policies: Basis of Presentation - The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Triumph Treatment Services under programs of the federal government for the year ended June 30, 2022. The information in this Schedule is presented in accordance with requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements of Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Triumph Treatment Services, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Triumph Treatment Services. Significant Accounting Policies - Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Expenditures - This column reports grant expenditures incurred and outstanding loan balances, with the exception of the Provider Relief Funds (CFDA 93.498). Published audit guidance dictates when funds are to be included. Accordingly, the payments received between April 10, 2020 and December 31, 2020 (Periods 1 and 2) are being reported in the current year Schedule.
De Minimis Rate Used: N
Rate Explanation: The auditee did not use the de minimis cost rate.
HOME INVESTMENT PARTNERSHIPS PROGRAM (14.239) - Balances outstanding at the end of the audit period were 252846.